Main Line biopharma firm behind Covid-19 therapy raises $30M to advance product line By: Philadelphia Business Journal via Business Journals August 24, 2021 at 12:41 PM EDT The Radnor company recently received its first regulatory approval for its Covid-19 treatment. Read More >> Related Stocks: Harbor Disruptive Innovation ETF